Key result
Higher tPA/PAI-1 complex levels are linked to ~2.7-fold higher odds of first-ever stroke.
Why the study?
Only a few studies had linked fibrinolytic system abnormalities to increased stroke risk, leaving uncertain whether plasma levels of tPA, PAI-1, and tPA/PAI-1 complex could predict a first-ever stroke.
Do plasma levels of tPA, PAI-1, and tPA/PAI-1 complex predict the development of a first-ever stroke?
Case-Control (n=324)
Yes
Do plasma levels of tPA, PAI-1, and tPA/PAI-1 complex predict the development of a first-ever stroke?
Answers are grounded in this paper and cite their sources.
Elevated plasma tPA/PAI-1 complex is an independent risk factor for the development of a first-ever stroke, particularly hemorrhagic stroke, indicating that fibrinolytic disturbances precede cerebrovascular events.
Background and Purpose —Abnormalities in the fibrinolytic system have been associated with an increased risk for stroke in a few studies. This study was designed to test whether plasma levels of tissue plasminogen activator (tPA), plasminogen activator inhibitor-1 (PAI-1), and tPA/PAI-1 complex could predict a first-ever stroke. Methods —The study was an incident case-control study nested within the Västerbotten Intervention Program and the Northern Sweden Monitoring Trends and Determinants in Cardiovascular Disease (MONICA) cohorts. In this study 108 first-ever stroke cases were defined according to the MONICA classification, and 216 controls from the same cohort were randomly selected and matched for age, sex, sampling time, and geographic region. Results —Stroke occurred on average 30 months after the blood sampling date. The mean plasma concentration of tPA/PAI-1 complex was higher for the stroke cases than for the controls (3.9 versus 3.0 μg/L). In univariate regression analysis, significantly higher odds ratios were found for the tPA/PAI-1 complex as continuous variable. When divided into quartiles, the odds ratio was 2.74 for the highest quartile compared with the lowest. In the multivariate model, the tPA/PAI-1 complex remained an independent predictor for stroke. Additionally, tPA mass concentration quartiles 3 and 4 showed a significant association with all stroke as outcome. No association was found, however, for PAI-1. In subgroup analysis of cerebral hemorrhage (n=18), the mean tPA/PAI-1 complex level was higher for the cases than for the controls (4.8 versus 3.0 μg/L), and in multivariate analysis including all controls (n=216), only tPA/PAI-1 complex remained significant. Conclusions —This prospective study shows that tPA/PAI-1 complex, a novel fibrinolytic marker, is independently associated with the development of a first-ever stroke, especially hemorrhagic stroke. This finding supports the hypothesis that disturbances in fibrinolysis precede a cerebrovascular event.
No takes yet. Share an insight, caveat, or question.
Johansson et al. (2000) conducted a case-control in First-ever stroke (n=324). Plasma levels of tPA, PAI-1, and tPA/PAI-1 complex vs. 216 randomly selected controls matched for age, sex, sampling time, and geographic region (and lowest quartile of biomarker levels) was evaluated on First-ever stroke (OR 2.74). Higher plasma tPA/PAI-1 complex levels independently predicted first-ever stroke (highest vs lowest quartile OR 2.74; mean 3.9 vs 3.0 μg/L in cases vs controls).
Synapse has enriched 10 related papers. Consider them for comparative context: